Full Text
Orphan Drugs in the German Early Benefit Assessment– Real World Versus G-Ba Bureaucracy

Abstract

Authors

A. Lebioda M. Hülsebeck S. Plantör

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×